Related Experiment Videos
Pigment epithelium-derived factor Met72Thr polymorphism in patients with diabetic microangiopathy
S Yamagishi1, S Amano, Y Inagaki
1Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. shoichi@med.kurume-u.ac.jp
Abstract:
Pigment epithelium-derived factor (PEDF) has recently been shown to be the most potent inhibitor of angiogenesis in the mammalian eye. We, along with others, have very recently found that loss of PEDF is involved in the development and progression of diabetic retinopathy. However, there are no studies on the allelic effects of PEDF gene polymorphism in diabetic retinopathy. In this study, we investigated whether a functional amino acid change, a methionine to threonine polymorphism (Met72Thr polymorphism) of the PEDF gene, is associated with microangiopathy in 143 patients with diabetes. We found that there were no significant associations between PEDF Met72Thr gene polymorphism and diabetic microangiopathy. These observations suggest that these genetic variants might not be involved in the mechanism of diabetic microangiopathy in patients with diabetes.
Insights
Pigment epithelium-derived factor (PEDF) inhibits eye angiogenesis. This study found no link between PEDF gene variations and diabetic microangiopathy, suggesting these specific genetic changes are not involved in the disease mechanism.
Area of Science:
- Ophthalmology
- Genetics
- Diabetology
Background:
- Pigment epithelium-derived factor (PEDF) is a key inhibitor of angiogenesis in the eye.
- Loss of PEDF is implicated in the development and progression of diabetic retinopathy.
- The role of PEDF gene polymorphism in diabetic retinopathy remains unstudied.
Purpose of the Study:
- To investigate the association between a specific PEDF gene polymorphism (Met72Thr) and diabetic microangiopathy.
- To explore the potential role of allelic variations in PEDF in the pathogenesis of diabetic complications.
Main Methods:
- Genotyping of the PEDF Met72Thr polymorphism in 143 diabetic patients.
- Analysis of the association between the polymorphism and the presence of diabetic microangiopathy.
Main Results:
- No significant association was found between the PEDF Met72Thr gene polymorphism and diabetic microangiopathy.
- The studied genetic variants of the PEDF gene do not appear to be a major factor in the development of diabetic microangiopathy.
Conclusions:
- The PEDF Met72Thr polymorphism is not significantly associated with diabetic microangiopathy in the studied cohort.
- These findings suggest that specific genetic variations in the PEDF gene may not play a critical role in the mechanism of diabetic microangiopathy.